2 weeks Ago By [email protected] (MENAFN)
( MENAFN - GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Postoperative Pain pipeline constitutes 45+ key companies continuously working towards developing 50+ Postoperative Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Postoperative Pain Pipeline Insight, 2024 " report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Postoperative Pain Market. The Postoperative Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.
The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. Some of the key takeaways from the Postoperative Pain Pipeline Report: Companies across the globe are diligently working toward developing novel Postoperative Pain treatment therapies with a considerable amount of success over the years. Postoperative Pain companies working in the treatment market are InSitu Biologics, Bexson Biomedical, Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc.
, Jiangsu HengRui Medicine Co., Ltd., Concentric Analgesics, Oculis Pharma, Haisco Pharmaceutical Group, Vivozon Pharmaceutical Inc, and others , are developing therapies for the Postoperative Pain treatment Emerging Postoperative Pain therapies in the different phases of clinical trials are- INSB-200, BB-106, ATX-201, ST-2427, LC-400, FX 301, NVK-009, HR021618, CA-008, OCS-01, HSK21542, VVZ-149, and others are expected to have a significant impact on the Postoperative Pain market in the coming years.
In September 2024, PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company") , a clinical-stage specialty pharmaceutical firm dedicated to reformulating existing therapies, has announced promising results concerning the compatibility of sutures in human clinical trials for its lead product, PRF-110. This product is intended to offer prolonged, non-opioid pain relief following surgery.
Postoperative Pain Overview Postoperative pain refers to the discomfort and pain experienced by patients after undergoing surgical procedures. This type of pain is a normal part of the recovery process and can vary in intensity depending on several factors, including the type and extent of surgery, individual pain thresholds, and the effectiveness of pain management strategies. It can manifest as sharp, aching, or throbbing sensations and may be localized to the surgical site or more generalized.
Effective management of postoperative pain is crucial for enhancing patient recovery, minimizing complications, and improving overall satisfaction with the surgical experience. Treatment options may include medications such as opioids, non-opioid analgesics, nerve blocks, and multimodal approaches to address pain from multiple angles. Get a Free Sample PDF Report to know more about Postoperative Pain Pipeline Therapeutic Assessment- Emerging Postoperative Pain Drugs Under Different Phases of Clinical Development Include: INSB-200: InSitu Biologics BB-106: Bexson Biomedical ATX-201: Allay Therapeutics ST-2427: SiteOne Therapeutics LC-400: LipoCure FX 301: Flexion Therapeutics NVK-009: Nevakar, Inc.
HR021618: Jiangsu HengRui Medicine Co., Ltd. CA-008: Concentric Analgesics OCS-01: Oculis Pharma HSK21542: Haisco Pharmaceutical Group VVZ-149: Vivozon Pharmaceutical Inc Postoperative Pain Route of Administration Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.
Products have been categorized under various ROAs, such as Oral Parenteral Intravenous Subcutaneous Topical Postoperative Pain Molecule Type Postoperative Pain Products have been categorized under various Molecule types, such as Monoclonal Antibody Peptides Polymer Small molecule Gene therapy Postoperative Pain Pipeline Therapeutics Assessment Postoperative Pain Assessment by Product Type Postoperative Pain By Stage and Product Type Postoperative Pain Assessment by Route of Administration Postoperative Pain By Stage and Route of Administration Postoperative Pain Assessment by Molecule Type Postoperative Pain by Stage and Molecule Type DelveInsight's Postoperative Pain Report covers around 50+ products under different phases of clinical development like Late-stage products (Phase III) Mid-stage products (Phase II) Early-stage product (Phase I) Pre-clinical and Discovery stage candidates Discontinued & Inactive candidates Route of Administration Further Postoperative Pain product details are provided in the report. Download the Postoperative Pain pipeline report to learn more about the emerging Postoperative Pain therapies Some of the key companies in the Postoperative Pain Therapeutics Market include: Key companies developing therapies for Postoperative Pain are - Bayer AG, Haleon PLC (GSK), Pacira Pharmaceuticals Inc., Johnson & Johnson (Janssen Pharmaceuticals), AFT Pharmaceuticals, Alembic Pharmaceuticals, Cipla Inc.
(InvaGen Pharmaceuticals Inc.), AbbVie (Allergan), Heron Therapeutics, Cali Biosciences, Innocoll, SiteOne Therapeutics, Pfizer Inc., and others.
Postoperative Pain Pipeline Analysis: The Postoperative Pain pipeline report provides insights into The report provides detailed insights about companies that are developing therapies for the treatment of Postoperative Pain with aggregate therapies developed by each company for the same. It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain Treatment. Postoperative Pain key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Postoperative Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Postoperative Pain market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Postoperative Pain drugs and therapies Postoperative Pain Pipeline Market Drivers Rise in the number of surgical procedures worldwide, government's initiative to promote better postoperative pain treatment are some of the important factors that are fueling the Postoperative Pain Market. Postoperative Pain Pipeline Market Barriers However, adverse effects associated with the medications, research Gaps in Practice Guidelines for Acute Postoperative Pain Management and other factors are creating obstacles in the Postoperative Pain Market growth. Scope of Postoperative Pain Pipeline Drug Insight Coverage: Global Key Postoperative Pain Companies: InSitu Biologics, Bexson Biomedical, Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc.
, Jiangsu HengRui Medicine Co., Ltd., Concentric Analgesics, Oculis Pharma, Haisco Pharmaceutical Group, Vivozon Pharmaceutical Inc, and others Key Postoperative Pain Therapies: INSB-200, BB-106, ATX-201, ST-2427, LC-400, FX 301, NVK-009, HR021618, CA-008, OCS-01, HSK21542, VVZ-149, and others Postoperative Pain Therapeutic Assessment: Postoperative Pain current marketed and Postoperative Pain emerging therapies Postoperative Pain Market Dynamics: Postoperative Pain market drivers and Postoperative Pain market barriers Request for Sample PDF Report for Postoperative Pain Pipeline Assessment and clinical trials Table of Contents 1.
Postoperative Pain Report Introduction 2. Postoperative Pain Executive Summary 3. Postoperative Pain Overview 4.
Postoperative Pain- Analytical Perspective In-depth Commercial Assessment 5. Postoperative Pain Pipeline Therapeutics 6. Postoperative Pain Late Stage Products (Phase II/III) 7.
Postoperative Pain Mid Stage Products (Phase II) 8. Postoperative Pain Early Stage Products (Phase I) 9. Postoperative Pain Preclinical Stage Products 10.
Postoperative Pain Therapeutics Assessment 11. Postoperative Pain Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13.
Postoperative Pain Key Companies 14. Postoperative Pain Key Products 15. Postoperative Pain Unmet Needs 16 .
Postoperative Pain Market Drivers and Barriers 17. Postoperative Pain Future Perspectives and Conclusion 18. Postoperative Pain Analyst Views 19.
Appendix 20. About DelveInsight About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. MENAFN05112024003238003268ID1108854789 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article.
If you have any complaints or copyright issues related to this article, kindly contact the provider above..
